Skip to main content
OpenTrials

Clinical trial condition

Polycystic Kidney, Autosomal Recessive

Explore clinical trials studying Polycystic Kidney, Autosomal Recessive. Study availability and eligibility vary by location and protocol.

7 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Polycystic Kidney, Autosomal Recessive trial results

Recruiting

A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

NCT04782258

Conditions
Abnormalities, Multiple, Autosomal Recessive Polycystic Kidney (ARPKD), Ciliopathies, +14 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • Northwestern University Feinberg School of Medicine - Ann & Robert H. Lurie Children's Hospital of Chicago - Neonatology Chicago, Illinois, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
View all 23 locations
View Trial Details
Recruiting

ARPKD Database Study

NCT01401998

Conditions
Abnormalities, Multiple, Agenesis of Cerebellar Vermis, Autosomal Recessive Polycystic Kidney Disease, +39 more
Locations
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Emory Atlanta, Georgia, United States
  • Boston Children's Boston, Massachusetts, United States
  • Cincinnati Children's Cincinnati, Ohio, United States
View Trial Details

Related conditions